Results 81 to 90 of about 3,200 (166)
The Intersection of m6A Methylation and Immune Response in PCOS: A Bioinformatics Perspective
N6‐methyladenosine RNA methylation regulators are intricately linked with the development of polycystic ovary syndrome (PCOS) and may influence immune cell infiltration in affected individuals. This study enhances our understanding of the molecular interactions in PCOS and suggests potential biomarkers for diagnosis and targets for therapeutic ...
Wenting Xu +8 more
wiley +1 more source
Lingdun Zhuge,1,2,* Binhao Huang,1,2,* Juntao Xie,1,2 Zhendong Gao,1,2 Difan Zheng,1,2 Shanbo Zheng,1,2 Jiaqing Xiang,1,2 Jie Zhang3 1Department of Thoracic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China ...
Zhuge L +7 more
doaj
Immunoscore for (colorectal) cancer precision medicine [PDF]
Shuji, Ogino, Marios, Giannakis
openaire +2 more sources
Background and purpose: Immunoscore® is a prognostic parameter based on densities of lymphocyte populations in the tumor center and invasive margin. Immunoscore® is validated in colorectal cancer as a high Immunoscore® is associated with longer survival.
Jonne Åkerla +7 more
doaj +1 more source
Quantifying Immunoscore performance – Authors' reply [PDF]
Franck, Pagès +2 more
openaire +2 more sources
Immunoscore: redefining the landscape of colorectal cancer control and care
The Immunoscore (IS), introduced by Jerome Galon in the early 2000s, evaluates immune cell densities within tumors, offering a more accurate prediction of clinical outcomes in colorectal cancer (CRC) compared to the TNM system. Studies have demonstrated that IS enhances the prediction of recurrence, disease-free survival, and overall survival in early ...
John Zakhour +10 more
openaire +2 more sources
Classificação Immunoscore em Carcinoma Colorretal
Trabalho Final do Mestrado Integrado em Medicina apresentado à Faculdade de ...
openaire +1 more source
Background Tumor-infiltrating lymphocytes (TILs) and the derived immunoscore (IS) have gained considerable attention over the last decade as prognostic markers in many solid cancers.
Sarra Ben Rejeb +4 more
doaj +1 more source
The success of immunotherapies brings hope for the future of cancer treatment. Even so, we are faced with a new challenge, that of understanding which patients will respond initially and, possibly, develop resistance.
João Paulo Portela Catani +3 more
doaj +1 more source
[Recent Advances in Peripheral Immunoscore in Lung Cancer].
Lung cancer is the malignant tumor with the highest morbidity and mortality. The tumor-node-metastasis (TNM) staging has gradually shown its limitations in the accurate prediction of lung cancer, so it is urgent to construct a new clinical predictive model to guide the prevention and treatment of lung cancer.
Fan XU +5 more
openaire +2 more sources

